English

23, 24 MAY
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PARTICIPANTS PROFILE

Product categories

Branded generics: 48.3%

Biological products: 34.5%

Biosimilars: 20.7%

Hospital products: 34.5%

Innovative medicines: 55.0%

more info




Partnering Strategy/Interests

In-licensing: 55.2%

Out-licensing: 46.6%

Co-marketing: 37.9%

Co-promotion: 37.9%

Co-development: 53.4%

more info




Therapeutic areas

Cardiovascular: 51.7%

CNS: 50.0%

Infectious diseases: 32.8%

Pain: 48.3%

Respiratory: 36.2%

more info



PARTICIPANTS 2019

Allergy/immunology: 19.8%

Cardiovascular: 51.7%

CNS: 50.0%

Dentistry: 2.6%

Dermatology: 18.1%

Drug delivers technol.: 23.3%

Gastroenterology: 22.4%

Gerontology: 11.2%

Gynecology: 22.4%

Infectious diseases: 32.8%

Hematology: 10.4%

Ophthalmology: 13.8%

Oncology: 18.1%

Orthopedics: 17.2%

Pain: 48.3%

Pediatrics: 15.5%

Psychiatrics: 19.0%

Respiratory: 36.2%

Rheumatology: 16.4%

Urology: 17.2%

Vaccines: 10.3%

Sponsor

patrocinador

partner